Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GBLT Corp GBLTF

GBLT Corp., through its subsidiary, GBT GmbH, designs, manufactures and supplies mobile storage and battery solutions. The Company is also a provider of renewable energy solutions via its solar division, participating in the solar energy market. In addition, the Company offers consumer healthcare and wellness products to retail chains across the globe. It is also an official licensee for AGFAPHOTO mobile energy products. The Company manufactures and distributes a range of mobile energy products worldwide, such as batteries, rechargeable batteries and chargers. The Company’s branded healthcare and wellbeing products are primarily sold throughout Europe under Dr. Senst brand. Through Dr. Senst brand, it offers electronic personal protection equipment (PPE) products, such as fever thermometers, blood pressure oximeters and others. The Company is also the official licensee of Avide / ENTAC light emitting diodes (LED) lighting products.


GREY:GBLTF - Post by User

Comment by chiefdilzon Nov 30, 2020 10:46am
78 Views
Post# 32000074

RE:Q3 2020 Announced

RE:Q3 2020 Announced
If extrapolate the 9 months to 12 months (not accounting for growth trend) it looks like we are trading at just over 7 times earnings (p/e ratio) and .36 sales (p/s ratio).  
The average healthcare related co out there trades at 24 times earnings and in general a p/s ratio of under 1 is considered a good buy (and between 1 and 2 a fair value). 
 Using these ratios would give a shareprice of .36 (using a 1:1 p/s ratio) and .72 using 2:1 ratio.    Applying the 24x multiple for healthcare industry using $1.96 million would give a shareprice of .42.


This website indicates that the ratios for the indusctry are higher than those above:
https://csimarket.com/Industry/Industry_Valuation.php?s=800
<< Previous
Bullboard Posts
Next >>